KOBI JONES: Open Payments
NPI 1275769796 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$227 in 8 payments from 6 companies in 2025. Trend: 2023 $35 · 2024 $13 · 2025 $227
Food & beverage: $227
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $117 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| ABBVIE INC. | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Amgen Inc. | 1 | $15 |
Products named: Ozempic, Symbravo, Rybelsus, AIRSUPRA, QULIPTA, NEXLETOL, OTEZLA.
Industry payments across MS — which companies pay providers there.
